*Kaempferia parviflora* or Krachaidum (in Thai), also known as "Thai ginseng," is a medicinal plant in the family Zingiberaceae. It is found in tropical areas such as Malaysia, Sumatra, Borneo Island, and Thailand. Its rhizome has been long used as folk medicine for many centuries.^[@bibr1-2156587216669628]^ Among the Hmong hill tribe, Krachaidum is widely believed to reduce perceived effort, improve physical work capacity, and prolong hill trekking. A number of pharmacological studies of Krachaidum have shown the following properties: antiallergenic,^[@bibr2-2156587216669628],[@bibr3-2156587216669628]^ anti-inflammatory,^[@bibr4-2156587216669628]^ antimutagenic,^[@bibr5-2156587216669628]^ antidepressive,^[@bibr6-2156587216669628]^ anticholinesterase,^[@bibr7-2156587216669628]^ antimicrobial,^[@bibr8-2156587216669628],[@bibr9-2156587216669628]^ anticancer,^[@bibr10-2156587216669628][@bibr11-2156587216669628]--[@bibr12-2156587216669628]^ anti---peptic ulcer,^[@bibr13-2156587216669628]^ cardioprotective,^[@bibr14-2156587216669628],[@bibr15-2156587216669628]^ antiobesity activity,^[@bibr16-2156587216669628]^ and aphrodisiac.^[@bibr17-2156587216669628][@bibr18-2156587216669628][@bibr19-2156587216669628]--[@bibr20-2156587216669628]^

Phytochemicals of Krachaidum contain 2 major constituents: 5,7-dimethoxyflavone and 5,7,4′-trimethoxyflavone.^[@bibr21-2156587216669628]^ In an in vitro study, methoxyflavone was examined for its inhibitory activities against nitric oxide production. Compound 5 (5-hydroxy-3,7,30,40-tetramethoxyflavone) exhibited the highest activity, followed by compounds 4 (5-hydroxy-7,40-dimethoxyflavone) and 3 (5-hydroxy-3,7,40-trimethoxyflavone), whereas other compounds possessed moderate or weak activity.^[@bibr4-2156587216669628]^ In addition, more than 20 chemically identifiable constituents have been reported to have potent pharmacological effects.^[@bibr22-2156587216669628]^ For example, flavonoids contained in Krachaidum rhizome extract was reported to possess antioxidant activity, neuroprotective effects, and cognition-enhancing effects.^[@bibr21-2156587216669628]^ Methoxyflavone substances in Krachaidum showed an inhibitory effect of phosphodiesterase types 5 and 6, which enhanced sexual performance.^[@bibr20-2156587216669628]^ For antimicrobial activity, 5,7,4′-trimethoxyflavone and 5,7,3′,4′-tetramethoxyflavone exhibited antiplasmodial activity against *Plasmodium falciparum*, and 3,5,7,4′-tetramethoxyflavone showed antifungal activity against *Candida albicans.*^[@bibr8-2156587216669628]^ For cholinesterase inhibitory effect, Krachaidum showed the potential inhibitors toward acetylcholinesterase and butyrylcholinesterase, which may be of great interest to be considered as a treatment agent for Alzheimer's disease.^[@bibr7-2156587216669628]^ Considering adverse events of Krachaidum used, an animal histopathological study of visceral organs revealed no remarkable lesions related to the toxicity of Krachaidum extract.^[@bibr23-2156587216669628]^

According to the anecdotal evidence of safety and efficacy, Krachaidum has been selected in Thailand as 1 of the 5 champion herbal products that have been widely used and have generated income to the country.^[@bibr22-2156587216669628],[@bibr24-2156587216669628]^ However, even though widely used for a long time and having shown benefits, clinical studies in human are still limited. Therefore, this study aims to systematically search and summarize the evidence in favor Krachaidum from existing clinical trials in all identified indications.

Methods {#section1-2156587216669628}
=======

This systematic review was conducted in line with the Cochrane Collaboration framework guidelines,^[@bibr25-2156587216669628]^ and the study follows the PRISMA Statement.^[@bibr26-2156587216669628]^

Search Strategies {#section2-2156587216669628}
-----------------

The following databases were used to search for original research articles from inception to January 2016: PubMed, EMBASE, Cochrane Central Register of Clinical Trials, CINAHL, AMED, WHO Registry, [www.clinicaltrial.gov](http://www.clinicaltrial.gov), Health Science Journals in Thailand, Thai Library Integrated System, Thai Thesis Database, Thai Index Medicus, and Thai Medical Index. Strategic search terms included "*Kaempferia parviflora*," "Black ginger," "Krachaidum" (a Thai word for *Kaempferia parviflora*), or other synonym names. References of articles derived for full-text review were scanned to identify potential studies not indexed in the above databases.

Study Selection {#section3-2156587216669628}
---------------

Studies were included if they met the following inclusion criteria: (1) conducted in humans, (2) evaluated clinical effects of Krachaidum, and (3) had a control group. Two authors (SS and PW) independently scanned all the titles and abstracts to determine whether the studies assessed the clinical effects of Krachaidum. Full-text articles of the potential studies were subsequently assessed by SS and PW. When disagreements and uncertainties regarding eligibility occurred, they were resolved by consensus discussions.

Data Extraction {#section4-2156587216669628}
---------------

Two authors (PW and PR) independently extracted data using a data extraction form and confirmed by a third author (SS) in line with the CONSORT statement for reporting herbal medicinal interventions.^[@bibr27-2156587216669628]^ The data extracted and reported included the following: study design, number of participants, age of participants, herbal compress ingredients, characteristics of the intervention, and outcome measurement. Outcomes of interest depended on indication of Krachaidum, for example, physical or exercise performance, erectile response.

Quality Assessment {#section5-2156587216669628}
------------------

Studies included in this review were assessed for methodological quality by SS and PW using the Cochrane risk of bias tool^[@bibr25-2156587216669628]^ and Jadad score.^[@bibr28-2156587216669628]^ The Cochrane risk of bias evaluates bias in intervention studies based on a number of criteria, including the following: sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting, and other sources of bias. Studies in which baseline characteristics were different among study groups or not tested for their difference were considered as high risk for the domain of "other risk of bias." Each study was classified as having low risk (low risk of bias for all key domains), high risk (high risk of bias for one or more key domains), or unclear risk (unclear risk of bias for one or more key domains). Disagreements between the reviewers were settled through discussion and consensus.

Statistical Analysis {#section6-2156587216669628}
--------------------

Data from all studies were pooled in a meta-analysis to determine the overall effect size with 95% confidence interval. Pooled effects were calculated and stratified according to indications of Krachaidum and its comparators. The outcome variables were compared between intervention and comparator arms by calculating the overall mean differences, which could be (1) standardized mean difference for outcomes that were measured by different scales across studies; or (2) weighted mean difference for outcomes that were measured on the same scale.^[@bibr25-2156587216669628]^

Statistical heterogeneity between studies was assessed using the χ^2^ test and *I*^2^. Thresholds of *I*^2^ were interpreted in accordance with the magnitude and direction of effects and strength of evidence of heterogeneity (ie, *P* value) as follows: might not be important (0% to 40%), moderate heterogeneity (30% to 60%), substantial heterogeneity (50% to 90%), and considerable heterogeneity (75% to 100%).^[@bibr25-2156587216669628]^ The DerSimonian and Laird random-effects model^[@bibr29-2156587216669628]^ was employed for all analyses. Meta-analyses were conducted using STATA version 14 (STATA Corp, College Station, TX).

Results {#section7-2156587216669628}
=======

Study Selection {#section8-2156587216669628}
---------------

A total of 683 records were identified through database searching (n = 680) and other sources (n = 3). A total of 462 records remained after duplicates were removed. Of the remaining 462 records, 378 were deemed ineligible based on title and abstract. Of the 84 articles qualified for a full-text review, 77 full-text articles were excluded because they did not meet the study eligibility criteria. The flow chart in [Figure 1](#fig1-2156587216669628){ref-type="fig"} presents the results describing exclusions at different stages during the review process. Seven studies were included in this systematic review.^[@bibr30-2156587216669628][@bibr31-2156587216669628][@bibr32-2156587216669628][@bibr33-2156587216669628][@bibr34-2156587216669628][@bibr35-2156587216669628]--[@bibr36-2156587216669628]^

![Flow diagram of selected articles.](10.1177_2156587216669628-fig1){#fig1-2156587216669628}

Characteristics of the Included Studies {#section9-2156587216669628}
---------------------------------------

The general characteristics of included studies are presented in [Table 1](#table1-2156587216669628){ref-type="table"}. Of the 7 included randomized controlled trials, 6 studies were from Thailand,^[@bibr30-2156587216669628][@bibr31-2156587216669628][@bibr32-2156587216669628][@bibr33-2156587216669628][@bibr34-2156587216669628]--[@bibr35-2156587216669628]^ and 1 study was done in Japan.^[@bibr36-2156587216669628]^ Five studies were conducted in healthy volunteers,^[@bibr30-2156587216669628][@bibr31-2156587216669628]--[@bibr32-2156587216669628],[@bibr34-2156587216669628],[@bibr36-2156587216669628]^ and one each studied in male soccer players^[@bibr33-2156587216669628]^ and patients with diagnosed osteoarthritis.^[@bibr35-2156587216669628]^ Among the included studies that reported patients' age and gender, the average age ranged from 16 to 66 years, and all patients were men in 5 studies,^[@bibr30-2156587216669628],[@bibr31-2156587216669628],[@bibr33-2156587216669628],[@bibr34-2156587216669628],[@bibr36-2156587216669628]^ except the study of Chalee,^[@bibr35-2156587216669628]^ which consisted of 26.5% of men, while one study did not report gender of participants.^[@bibr32-2156587216669628]^ Most studies used Krachaidum as powder in capsule and compared with placebo, except the study of Chalee,^[@bibr35-2156587216669628]^ which used Krachaidum as cream and compared with analgesic creams. Duration of study varied from 90 minutes^[@bibr31-2156587216669628],[@bibr36-2156587216669628]^ to 4 weeks,^[@bibr35-2156587216669628]^ 8 weeks,^[@bibr30-2156587216669628],[@bibr32-2156587216669628],[@bibr34-2156587216669628]^ and 12 weeks.^[@bibr33-2156587216669628]^ Considering outcomes of interest, 4 studies focused on physical or exercise performance,^[@bibr30-2156587216669628][@bibr31-2156587216669628][@bibr32-2156587216669628]--[@bibr33-2156587216669628]^ while one each focused on erectile response,^[@bibr34-2156587216669628]^ pain indicators,^[@bibr35-2156587216669628]^ and energy expenditure.^[@bibr36-2156587216669628]^ All studies reported that they used standardized extract of Krachaidum. Three studies reported that they used thin-layer chromatography fingerprint^[@bibr30-2156587216669628]^ or high-performance liquid chromatography,^[@bibr31-2156587216669628],[@bibr36-2156587216669628]^ while 4 studies reported that a standardized extract of Krachaidum was prepared by the Center for Research and Development of Herbal Health Product, Faculty of Pharmaceutical Sciences, Khon Kaen University.^[@bibr32-2156587216669628][@bibr33-2156587216669628][@bibr34-2156587216669628]--[@bibr35-2156587216669628]^

###### 

Characteristics of the Included Studies.

![](10.1177_2156587216669628-table1)

  Study, Country                                              Design (Jadad Scale)               Participants' Characteristics                         N    Mean Age (in Years)   Men (%)   Intervention Group With Dose                                                                   Comparison Group                                                                          Standardization of Krachaidum                                                                                                                            Extraction Method   Outcomes              Duration of Study                                                                                                                                                                                          
  ----------------------------------------------------------- ---------------------------------- ----------------------------------------------------- ---- --------------------- --------- ---------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------- --------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  *Physical or exercise performance*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Deema (2007),^[@bibr30-2156587216669628]^ Thailand          RCT (Jadad = 3)                    Healthy males age 18-35 years                         30   22.0                  100       KP 1.35 g in capsules with endurance training (n = 11) or without endurance training (n = 5)   Placebo capsules with endurance training (n = 10) or without endurance training (n = 4)   Quantifying its content according the standard procedure                                                                                                 TLC fingerprint     Ethanol extract       Maximum power output (watt), Time to finish work max test (min), Heart rate (BPM), Lactate threshold (watt)                                                                                                8 weeks
  Wasuntarawat (2010),^[@bibr31-2156587216669628]^ Thailand   RCT (Jadad = 4)                    Healthy males                                         19   20.0                  100       KP 1.35 g in capsules                                                                          Placebo                                                                                   Validated by quantifying its content of 5,7-dimethoxyflavone and 5,7,40-trimethoxyflavone                                                                HPLC                NR                    Maximum power output (watt), Mean power output (watt), Time to exhaustion (min), Rating of perceived exertion, Percentage fatigue (%), Heart rate (BPM)                                                    90 minutes
  Wattanathorn (2012),^[@bibr32-2156587216669628]^ Thailand   RCT (Jadad = 4)                    Healthy elderly were older than 60 years              45   62.8                  NR        KP 25 mg in capsules (n = 15) and 90 mg (n = 15)                                               Placebo (n = 15)                                                                          Assured by strict in-process controls during manufacturing and complete analytical control of the resulting dry extract                                  KKU                 95% ethanol extract   Hand grip strength test (kg), 30-Second chair stand test (seconds), 6-Minute walk test (meter), Tandem test (seconds)                                                                                      8 weeks
  Promthep (2015),^[@bibr33-2156587216669628]^ Thailand       RCT (Jadad = 4)                    Males soccer players age 15-18 years                  60   16.0                  100       KP 180 mg in capsules (n = 30)                                                                 Placebo (n = 30)                                                                          Assured by strict in-process controls during manufacturing and complete analytical control of the resulting dry extract                                  KKU                 95% ethanol extract   Grip strength test (kg/wt), Back-and-leg test (kg/wt), Sit-and-reach test (cm), 40-Yard technical test (seconds), 50-Metre sprint test (seconds), Cardiorespiratory fitness (VO~2~ max) test (mL/kg/min)   12 weeks
  *Erectile response*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Wannanon (2012),^[@bibr34-2156587216669628]^ Thailand       RCT (Jadad = 5)                    Healthy elderly volunteers                            45   66.0                  100       KP 25 mg in capsules (n = 15) and 90 mg (n = 15)                                               Placebo (n = 15)                                                                          Assured by strict in-process controls during manufacturing and complete analytical control of the resulting dry extract                                  KKU                 95% ethanol extract   Latency time (min), Penile circumference and length (cm), Serum hormones concentrations (testosterone (ng/mL), FSH (IU/L), LH (IU/L)                                                                       8 weeks
  *Pain indicators*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Chalee (2010),^[@bibr35-2156587216669628]^ Thailand         RCT (Jadad = 5)                    Patients were older than 50 years with diagnosed OA   70   61.0                  26.5      KP 7%w/w creams applied 1 sachet (2 g) 3 time a day (n = 35)                                   Analgesic creams (n = 35)                                                                 KP 7%w/w                                                                                                                                                 KKU                 95% ethanol extract   Pain score, Circumference of knee joint (cm), Range of motion of knee joint (ROM), Modified WOMAC score                                                                                                    4 weeks
  *Energy expenditure*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Matsushita (2015),^[@bibr36-2156587216669628]^ Japan        RCT, crossover trial (Jadad = 1)   Healthy males aged 21-29 years                        20   24.1                  100       KP 100 mg/day in capsules                                                                      Placebo                                                                                   Revealed that the KP extract contained 3,5,7,4′-tetramethoxyflavone (2.16%), 5,7-dimethoxyflavone (4.07%), and 3,5,7,3′,4′-pentamethoxyflavone (4.25%)   HPLC                60% ethanol extract   Energy expenditure change (kJ/day)                                                                                                                                                                         90 minutes

Abbreviations: RCT, randomized controlled trial; KP, *Kaempferia parviflora*; N, number of participants; TLC, thin layer chromatography; BPM, beats per minute; HPLC, high-performance liquid chromatography; NR, not reported; KKU, a standardized extract of *Kaempferia parviflora* prepared by the Center for Research and Development of Herbal Health Product, Faculty of Pharmaceutical Sciences, Khon Kaen University; FSH, follicle-stimulating hormone; LH, luteinizing hormone; WOMAC, Western Ontario and McMaster Universities Arthritis Index; OA, osteoarthritis.

Quality Assessment {#section10-2156587216669628}
------------------

The methodological quality of the 7 randomized controlled trials included in the systematic review was high as shown by Jadad scale score of 3 (scale score range of 0-5), except the study of Matsushita et al,^[@bibr36-2156587216669628]^ which had a Jadad scale score of 1 ([Table 1](#table1-2156587216669628){ref-type="table"}). In addition, based on the risk of bias of key domains, overall risk of bias within the studies in most studies yielded unclear risk of bias ([Figure 2](#fig2-2156587216669628){ref-type="fig"}).

![Risk of bias: (A) Risk of bias in each study; (B) Summary risk of bias of included studies.](10.1177_2156587216669628-fig2){#fig2-2156587216669628}

Clinical Effects of Krachaidum on Physical or Exercise Performance {#section11-2156587216669628}
------------------------------------------------------------------

To determine the effects of Krachaidum on physical or exercise performance, many tests were used, including maximum power output, mean power output, time to exhaustion, rating of perceived exertion, percentage fatigue, heart rate, lactate threshold, hand grip strength, 6-minute walk test, and so on ([Table 2](#table2-2156587216669628){ref-type="table"}). The main findings from 2 studies^[@bibr30-2156587216669628],[@bibr31-2156587216669628]^ indicated that Krachaidum showed no acute improvement in either repeated sprint performance or endurance exercise. However, 2 studies^[@bibr32-2156587216669628],[@bibr33-2156587216669628]^ provided data of hand grip strength test, which determined the upper-body muscle strength by using a digital dynamometer. We pooled such data based on this outcome and found that they were combinable without heterogeneity (*I*^2^ = 0%, *P* \> .05). We found that the Krachaidum group significantly increased hand grip strength of both right-hand (standardized mean difference = 0.44, 95% confidence interval = 0.02-0.86, *P* = .038) and left-hand sides (standardized mean difference = 0.49, 95% confidence interval = 0.07-0.91, *P* = .048) at 2 months compared with the placebo group ([Figure 3](#fig3-2156587216669628){ref-type="fig"}).

###### 

Clinical Effects of Krachaidum Classified by Outcomes.

![](10.1177_2156587216669628-table2)

                                                               Outcomes, Study      Sample Subgroup                          Interventions                  Time or Methods of Measurement   *Kaempferia parviflora*    Control       Summary                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  ------------------------------------------------------------ -------------------- ---------------------------------------- ------------------------------ -------------------------------- -------------------------- ------------- --------- --------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------
  ***Physical or exercise performance***                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  **Maximum power output (watt)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                               Deema, 2007          Endurance training groups                KP 1.35 g/day vs placebo       Baseline                         203.50                     3.30          214.20    2.40      Significantly increased at weeks 4 and 8 in the KP group and week 8 in the placebo group (difference from baseline)                                                                                                                                                                                                                                                                                                                                  
                                                                                                                             4 weeks                        233.70                           2.90                       232.10        1.60                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                             8 weeks                        245.00                           3.20                       247.00        2.90                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                    No endurance training groups                                            Baseline                         184.10                     2.80          200.80    4.90      No significant effects                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                             4 weeks                        190.50                           2.10                       197.40        5.30                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                             8 weeks                        192.00                           2.00                       198.20        5.30                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                               Wasuntarawat, 2010   Anaerobic exercise (exhaustive sprint)   KP 1.35 g/day vs placebo       Wingate 1                        545.00                     95.00         554.00    114.00    Maximum power output declined (*P* \< .05) across Wingate tests 1, 2, and 3 but there were no differences (*P* \> .05) between KP and placebo                                                                                                                                                                                                                                                                                                        
                                                                                                                             Wingate 2                      499.00                           99.00                      495.00        109.00                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                        Wingate 3     454.00    116.00    473.00                                                                                                                                                                                                                                                       96.00                                                                                                                                                                                   
  **Mean power output (watt)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                               Wasuntarawat, 2010   Anaerobic exercise (exhaustive sprint)   KP 1.35 g/day vs placebo       Wingate 1                        417.00                     65.00         416.00    65.00     Mean power output declined (*P* \< .05) across Wingate tests 1, 2, and 3 but there were no differences (*P* \> .05) between KP and placebo                                                                                                                                                                                                                                                                                                           
                                                                                                                             Wingate 2                      369.00                           59.00                      369.00        58.00                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                        Wingate 3     323.00    61.00     334.00                                                                                                                                                                                                                                                       57.00                                                                                                                                                                                   
  **Time to finish work max test (minutes)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                               Deema, 2007          Endurance training groups                KP 1.35 g/day vs placebo       Baseline                         8.20                       0.10          8.50      0.10      Significantly increased at weeks 4 and 8 in the KP group and week 8 in the placebo group (difference from baseline)                                                                                                                                                                                                                                                                                                                                  
                                                                                                                             4 weeks                        9.20                             0.10                       9.40          0.10                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                             8 weeks                        9.70                             0.10                       9.90          0.1 0                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                    No endurance training groups                                            Baseline                         7.20                       0.10          7.90      0.20      No significant effects                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                             4 weeks                        7.50                             0.10                       7.80          0.20                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                             8 weeks                        7.50                             0.10                       7.80          0.10                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  **Time to exhaustion (minutes)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                               Wasuntarawat, 2010   Anaerobic exercise (exhaustive sprint)   KP 1.35 g/day vs placebo                                        28.30                      12.50         27.60     11.50     Acute ingestion of KP did not improve time to exhaustion                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  **Rating of perceived exertion**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                               Wasuntarawat, 2010   Anaerobic exercise (exhaustive sprint)   KP 1.35 g/day vs placebo       10 min                           14.00                      2.00          14.00     2.00      Ratings of perceived exertion at 10 and 20 minutes and immediately after exhaustion were also not different between placebo and KP. Time to exhaustion was rated between 17 ("very hard") and 19 ("extremely hard")                                                                                                                                                                                                                                  
                                                                                                                             20 min                         17.00                            2.00                       17.00         2.00                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                        Post^a^       19.00     1.00      18.00                                                                                                                                                                                                                                                        1.00                                                                                                                                                                                    
  **Percentage fatigue (%)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                               Wasuntarawat, 2010   Anaerobic exercise (exhaustive sprint)   KP 1.35 g/day vs placebo       Wingate 1                        43.00                      13.00         40.00     15.00     No differences in percent fatigue during each 30-second sprint were observed between placebo and KP. Percent fatigue during the third Wingate test was significantly (*P* \< .05) greater than during the first Wingate test in both placebo and KP trials                                                                                                                                                                                           
                                                                                                                             Wingate 2                      48.00                            12.00                      44.00         15.00                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                        Wingate 3     51.00     13.00     53.00                                                                                                                                                                                                                                                        10.00                                                                                                                                                                                   
  **Heart rate (BPM)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                               Deema, 2007          Maximum heart rate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                             Endurance training groups      KP 1.35 g/day vs placebo         Baseline                   181.00        0.80      179.60    0.50                                                                                                                                                                                                                                                         Significantly increased at week 8 in the placebo group (difference from baseline)                                                                                                       
                                                                                                                                                            4 weeks                          184.70                     0.70          181.30    0.60                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                        8 weeks       184.60    0.80      186.60                                                                                                                                                                                                                                                       0.80                                                                                                                                                                                    
                                                                                                                             No endurance training groups                                    Baseline                   185.00        2.00      180.00    2.40                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                            4 weeks                          199.60                     0.60          176.20    2.60                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                        8 weeks       186.40    1.60      181.20                                                                                                                                                                                                                                                       1.80                                                                                                                                                                                    
                                                               Wasuntarawat, 2010   Aerobic exercise (endurance)             KP 1.35 g/day vs placebo       10 min                           165.00                     13.00         164.00    11.00     Heart rate at 10 and 20 minutes and immediately after exhaustion were also not different between placebo and KP                                                                                                                                                                                                                                                                                                                                      
                                                                                                                             20 min                         174.00                           10.00                      172.00        9.00                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                             Post^a^                        177.00                           8.00                       174.00        10.00                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  **Lactate threshold (watt)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                               Deema, 2007          Endurance training groups                KP 1.35 g/day vs placebo       Baseline                         129.60                     1.70          142.50    1.70      Significantly increased lactate threshold at weeks 4 and 8 in the KP group (difference from baseline)                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                        4 weeks       156.80    2.70      155.00                                                                                                                                                                                                                                                       2.30                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       165.90    3.3 0     160.00                                                                                                                                                                                                                                                       1.80                                                                                                                                                                                    
                                                                                    No endurance training groups                                            Baseline                         120.00                     4.20          120.00    4.20      No significant effects from baseline                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                             4 weeks                        118.80                           5.40                       118.80        6.00                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       118.80    2.80      106.30                                                                                                                                                                                                                                                       3.10                                                                                                                                                                                    
  **Hand grip strength test**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                               Wattanathorn, 2012   Right hand (kg)                          KP 25 mg/day vs placebo        Baseline                         25.06                      3.01          24.53     2.55      No significant effects                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                        4 weeks       25.00     2.97      24.33                                                                                                                                                                                                                                                        2.28                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       24.86     3.18      24.33                                                                                                                                                                                                                                                        2.46                                                                                                                                                                                    
                                                                                                                             KP 90 mg/day vs placebo        Baseline                         23.93                      3.30          ---       ---       No significant effects                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                        4 weeks       24.60     3.13      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       24.80     3.14      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                    Left hand (kg)                           KP 25 mg/day vs placebo        Baseline                         22.06                      1.86          21.06     1.83      No significant effects                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                        4 weeks       21.66     1.50      21.33                                                                                                                                                                                                                                                        1.58                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       21.26     1.48      21.20                                                                                                                                                                                                                                                        1.56                                                                                                                                                                                    
                                                                                                                             KP 90 mg/day vs placebo        Baseline                         20.86                      2.72          ---       ---       No significant effects                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                        4 weeks       21.60     2.02      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       21.60     1.84      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                               Promthep, 2015       Right hand (kg/wt)                       KP 180 mg/day vs placebo       Baseline                         0.65                       0.09          0.63      0.07      Significantly enhanced at weeks 4, 8, and 12 (difference from the placebo group in the same week) and significant difference compared with the baseline score at week 4                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                        4 weeks       0.70      0.09      0.66                                                                                                                                                                                                                                                         0.07                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       0.68      0.10      0.63                                                                                                                                                                                                                                                         0.07                                                                                                                                                                                    
                                                                                                                                                                                                                        12 weeks      0.65      0.08      0.62                                                                                                                                                                                                                                                         0.07                                                                                                                                                                                    
                                                                                    Left hand (kg/wt)                        KP 180 mg/day vs placebo       Baseline                         0.62                       0.08          0.60      0.08      Significantly enhanced at week 8 (difference from the placebo group in the same week)                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                        4 weeks       0.65      0.10      0.62                                                                                                                                                                                                                                                         0.07                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       0.64      0.08      0.59                                                                                                                                                                                                                                                         0.08                                                                                                                                                                                    
                                                                                                                                                                                                                        12 weeks      0.61      0.08      0.57                                                                                                                                                                                                                                                         0.07                                                                                                                                                                                    
  **30-Second chair stand test (seconds)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                               Wattanathorn, 2012                                                                                                            KP 25 mg/day vs placebo    Baseline      18.33     2.58      19.13                                                                                                                                                                                                                                                        2.79                                                                                                                                                                                    No significant effects
                                                                                                                                                                                                                        4 weeks       19.00     2.77      19.26                                                                                                                                                                                                                                                        1.43                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       20.00     3.11      18.93                                                                                                                                                                                                                                                        1.70                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      18.60     2.52      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     Significantly increased at week 8 compared with baseline
                                                                                                                                                                                                                        4 weeks       19.60     2.13      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       20.66     2.28      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
  **6-Minute Walk Test (m)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                               Wattanathorn, 2012                                                                                                            KP 25 mg/day vs placebo    Baseline      571.26    33.68     567.33                                                                                                                                                                                                                                                       33.52                                                                                                                                                                                   No significant effects
                                                                                                                                                                                                                        4 weeks       570.33    38.32     598.73                                                                                                                                                                                                                                                       31.57                                                                                                                                                                                   
                                                                                                                                                                                                                        8 weeks       575.53    36.04     571.26                                                                                                                                                                                                                                                       32.05                                                                                                                                                                                   
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      572.80    32.65     ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     Significantly increased at week 8 compared with either baseline or placebo
                                                                                                                                                                                                                        4 weeks       575.46    34.29     ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       601.26    33.70     ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
  **Tandem stance test (seconds)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                               Wattanathorn, 2012   Opened eye                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                             Right leg is in front          KP 25 mg/day vs Placebo          Baseline                   161.8         11.16     164.80    12.34                                                                                                                                                                                                                                                        No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        4 weeks       164.06    9.63      163.06                                                                                                                                                                                                                                                       10.35                                                                                                                                                                                   
                                                                                                                                                                                                                        8 weeks       162.26    8.93      165.06                                                                                                                                                                                                                                                       9.80                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      164.00    10.50     ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     No significant effects
                                                                                                                                                                                                                        4 weeks       166.60    6.81      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       168.46    6.90      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                             Left leg is in front           KP 25 mg/day vs placebo          Baseline                   111.93        7.77      112.33    11.00                                                                                                                                                                                                                                                        No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        4 weeks       112.33    11.39     110.66                                                                                                                                                                                                                                                       10.01                                                                                                                                                                                   
                                                                                                                                                                                                                        8 weeks       111.80    10.16     109.00                                                                                                                                                                                                                                                       10.20                                                                                                                                                                                   
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      108.20    11.32     ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     No significant effects
                                                                                                                                                                                                                        4 weeks       109.33    13.62     ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       111.80    13.31     ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                    Closed eye                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                             Right leg is in front          KP 25 mg/day vs placebo          Baseline                   31.86         10.12     33.80     9.22                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        4 weeks       32.60     7.44      30.80                                                                                                                                                                                                                                                        10.74                                                                                                                                                                                   
                                                                                                                                                                                                                        8 weeks       32.73     7.67      31.66                                                                                                                                                                                                                                                        10.41                                                                                                                                                                                   
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      31.26     11.09     ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     No significant effects
                                                                                                                                                                                                                        4 weeks       31.86     9.33      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       33.40     8.94      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                             Left leg is in front           KP 25 mg/day vs placebo          Baseline                   20.93         3.41      18.80     3.60                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        4 weeks       21.33     3.79      19.86                                                                                                                                                                                                                                                        5.01                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       21.26     3.19      21.20                                                                                                                                                                                                                                                        4.57                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      20.46     4.24      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     No significant effects
                                                                                                                                                                                                                        4 weeks       21.26     4.58      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
                                                                                                                                                                                                                        8 weeks       22.06     3.93      ---                                                                                                                                                                                                                                                          ---                                                                                                                                                                                     
  **A sit-and-reach test (cm)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                               Promthep, 2015                                                                                                                KP 180 mg/day vs placebo   Baseline      17.98     4.60      16.14                                                                                                                                                                                                                                                        4.93                                                                                                                                                                                    Significant difference compared with the baseline score at week 4 (both the treatment and placebo groups)
                                                                                                                                                                                                                        4 weeks       16.43     5.15      14.64                                                                                                                                                                                                                                                        4.92                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       16.88     5.19      14.61                                                                                                                                                                                                                                                        5.24                                                                                                                                                                                    
                                                                                                                                                                                                                        12 weeks      18.28     5.10      17.01                                                                                                                                                                                                                                                        4.55                                                                                                                                                                                    
  **A back-and-leg strength test (kg/wt)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                               Promthep, 2015                                                                                                                KP 180 mg/day vs placebo   Baseline      2.77      0.54      2.45                                                                                                                                                                                                                                                         0.39                                                                                                                                                                                    No significant effects
                                                                                                                                                                                                                        4 weeks       2.68      0.55      2.45                                                                                                                                                                                                                                                         0.51                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       2.77      0.55      2.44                                                                                                                                                                                                                                                         0.40                                                                                                                                                                                    
                                                                                                                                                                                                                        12 weeks      2.79      0.59      2.53                                                                                                                                                                                                                                                         0.52                                                                                                                                                                                    
  **A 40-yard technical test (seconds)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                               Promthep, 2015                                                                                                                KP 180 mg/day vs placebo   Baseline      11.61     0.07      11.99                                                                                                                                                                                                                                                        0.86                                                                                                                                                                                    Significantly decreased at week 12 compared with the baseline
                                                                                                                                                                                                                        4 weeks       12.06     1.16      12.34                                                                                                                                                                                                                                                        1.33                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       11.50     0.74      11.46                                                                                                                                                                                                                                                        0.75                                                                                                                                                                                    
                                                                                                                                                                                                                        12 weeks      10.08     0.47      10.47                                                                                                                                                                                                                                                        0.90                                                                                                                                                                                    
  **A 50-metre sprint test (seconds)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                               Promthep, 2015                                                                                                                KP 180 mg/day vs placebo   Baseline      6.24      0.31      6.29                                                                                                                                                                                                                                                         0.37                                                                                                                                                                                    No significant effects in both groups. No significant differences between the groups
                                                                                                                                                                                                                        4 weeks       6.26      0.31      6.33                                                                                                                                                                                                                                                         0.49                                                                                                                                                                                    
                                                                                                                                                                                                                        8 weeks       6.37      0.26      6.50                                                                                                                                                                                                                                                         0.50                                                                                                                                                                                    
                                                                                                                                                                                                                        12 weeks      6.33      0.24      6.47                                                                                                                                                                                                                                                         0.52                                                                                                                                                                                    
  **A cardiorespiratory fitness test VO~2~ max (mL/kg/min)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                               Promthep, 2015                                                                                                                KP 180 mg/day vs placebo   Baseline      45.09     9.88      45.09                                                                                                                                                                                                                                                        9.96                                                                                                                                                                                    Significantly increased cardiorespiratory fitness, as indicated by VO~2~ max values at week 12. No significant difference between the groups
                                                                                                                                                                                                                        4 weeks       46.95     7.61      47.85                                                                                                                                                                                                                                                        10.08                                                                                                                                                                                   
                                                                                                                                                                                                                        8 weeks       49.40     8.40      48.34                                                                                                                                                                                                                                                        7.17                                                                                                                                                                                    
                                                                                                                                                                                                                        12 weeks      51.05     8.40      47.10                                                                                                                                                                                                                                                        8.45                                                                                                                                                                                    
  ***Pain indicators***                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                               Chalee, 2010         Pain severity                            KP 7% w/w vs analgesic cream   Baseline                         8.11                       0.99          8.15      1.09      Significantly decreased at week 4 compared with the baseline (both the treatment and placebo groups). No significant difference between the groups                                                                                                                                                                                                                                                                                                   
                                                                                    4 weeks                                  6.80                           0.76                             6.87                       0.65                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                    Circumference of knee joint (cm)                                        Baseline                         37.91                      2.75          37.15     3.00                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                             4 weeks                        37.03                            2.56                       36.30         2.64                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                    Range of motion of knee joint (ROM)                                     Baseline                         110.57                     9.45          109.39    10.66                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                             4 weeks                        117.43                           5.86                       116.21        6.62                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                    Modified WOMAC score                                                    Baseline                         40.31                      6.63          39.97     6.02                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                             4 weeks                        39.29                            5.84                       39.00         5.50                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  ***Energy expenditure***                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                               Matsushita, 2015     Energy expenditure change (kJ/day)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                             All                            KP 100 mg/day vs placebo         Baseline                   6213.00       143.00    6196.00   150.00                                                                                                                                                                                                                                                       No significant in the placebo group but significant difference between the groups at 30 and 60 minutes, difference from baseline and maximal rise at 60 minutes                         
                                                                                                                                                                                                                        60 minutes    6442.00   212.00    NR                                                                                                                                                                                                                                                           NR                                                                                                                                                                                      
                                                                                                                             High-BAT                       KP 180 mg/day vs placebo         Baseline                   6076.00       184.00    6103.00   184                                                                                                                                                                                                                                                          No significant in the placebo group but significant difference between the groups at 30 and 60 minutes, difference from baseline at 30, 60, 90 minutes and maximal rise at 60 minutes   
                                                                                                                                                                                                                        60 minutes    6427.00   234.00    NR                                                                                                                                                                                                                                                           NR                                                                                                                                                                                      
                                                                                                                             Low-BAT                        KP 180 mg/day vs placebo         Baseline                   6418.00       223.00    6334.00   261.00                                                                                                                                                                                                                                                       No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        60 minutes    NR        NR        NR                                                                                                                                                                                                                                                           NR                                                                                                                                                                                      
  ***Erectile response***                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                               Wannanon, 2012       Penile circumference (cm)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                             Resting state                  KP 25 mg/day vs placebo          Baseline                   9.40          0.79      9.00      0.73                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        1 month       9.00      0.79      8.70                                                                                                                                                                                                                                                         0.59                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      9.40      0.79      8.80                                                                                                                                                                                                                                                         0.59                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      9.15      3.10      9.15                                                                                                                                                                                                                                                         3.10                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      9.20      0.69      9.00                                                                                                                                                                                                                                                         0.73                                                                                                                                                                                    After 1 and 2 months of treatment, significant increase in the length and width of penis when compared with the placebo treated group
                                                                                                                                                                                                                        1 month       10.20     0.79      8.70                                                                                                                                                                                                                                                         0.59                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      10.15     0.79      8.80                                                                                                                                                                                                                                                         0.59                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      9.65      2.71      9.15                                                                                                                                                                                                                                                         3.10                                                                                                                                                                                    
                                                                                                                             Erection state                 KP 25 mg/day vs placebo          Baseline                   10.90         3.87      11.50     3.87                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        1 month       10.50     3.68      10.60                                                                                                                                                                                                                                                        3.10                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      11.50     4.26      11.80                                                                                                                                                                                                                                                        2.71                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      11.70     3.10      11.70                                                                                                                                                                                                                                                        2.71                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      10.80     4.26      11.50                                                                                                                                                                                                                                                        3.87                                                                                                                                                                                    After 1 and 2 months of treatment, significant increase in the width when compared with the placebo treated group
                                                                                                                                                                                                                        1 month       12.10     4.26      10.60                                                                                                                                                                                                                                                        3.10                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      11.90     4.26      11.80                                                                                                                                                                                                                                                        2.71                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      11.70     0.39      11.70                                                                                                                                                                                                                                                        2.71                                                                                                                                                                                    
                                                                                    Penile length (cm)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                             Resting state                  KP 25 mg/day vs placebo          Baseline                   9.70          4.26      9.95      7.55                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        1 month       9.65      3.87      9.90                                                                                                                                                                                                                                                         3.49                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      10.90     3.87      10.00                                                                                                                                                                                                                                                        3.10                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      10.60     3.49      10.25                                                                                                                                                                                                                                                        0.07                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      9.40      4.07      9.95                                                                                                                                                                                                                                                         7.55                                                                                                                                                                                    After 1 and 2 months of treatment, significant increase in the length when compared with the placebo treated group
                                                                                                                                                                                                                        1 month       11.25     3.49      9.90                                                                                                                                                                                                                                                         3.49                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      11.10     2.71      10.00                                                                                                                                                                                                                                                        3.10                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      10.65     3.49      10.25                                                                                                                                                                                                                                                        0.07                                                                                                                                                                                    
                                                                                                                             Erection state                 KP 25 mg/day vs placebo          Baseline                   12.50         5.27      13.10     4.96                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        1 month       12.95     4.03      12.20                                                                                                                                                                                                                                                        3.87                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      13.10     4.34      12.40                                                                                                                                                                                                                                                        4.18                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      13.55     3.87      13.20                                                                                                                                                                                                                                                        2.79                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      12.90     4.34      13.10                                                                                                                                                                                                                                                        4.96                                                                                                                                                                                    After 1 and 2 months of treatment, significant increase in the length when compared with the placebo treated group
                                                                                                                                                                                                                        1 month       13.75     4.34      12.20                                                                                                                                                                                                                                                        3.87                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      13.90     4.03      12.40                                                                                                                                                                                                                                                        4.18                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      13.50     4.65      13.20                                                                                                                                                                                                                                                        2.79                                                                                                                                                                                    
                                                                                    Latency time (mins)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                             Erection state                 KP 25 mg/day vs placebo          Baseline                   10.90         13.94     11.60     12.39                                                                                                                                                                                                                                                        No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        1 month       8.60      12.39     11.70                                                                                                                                                                                                                                                        11.81                                                                                                                                                                                   
                                                                                                                                                                                                                        2 months      8.00      12.39     10.00                                                                                                                                                                                                                                                        10.65                                                                                                                                                                                   
                                                                                                                                                                                                                        Delay^b^      7.80      0.59      10.90                                                                                                                                                                                                                                                        12.78                                                                                                                                                                                   
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      10.40     9.30      11.60                                                                                                                                                                                                                                                        12.39                                                                                                                                                                                   Significantly decreased the response latency to sexual erotic stimuli and still showed the significant changes during the delay period
                                                                                                                                                                                                                        1 month       5.50      7.17      11.70                                                                                                                                                                                                                                                        11.81                                                                                                                                                                                   
                                                                                                                                                                                                                        2 months      5.50      6.58      10.00                                                                                                                                                                                                                                                        10.65                                                                                                                                                                                   
                                                                                                                                                                                                                        Delay^b^      7.40      6.20      10.90                                                                                                                                                                                                                                                        12.78                                                                                                                                                                                   
                                                                                    Serum hormones concentrations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                             Testosterone (ng/mL)           KP 25 mg/day vs placebo          Baseline                   4.11          1.56      4.14      0.92                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        Single dose   4.79      4.63      5.28                                                                                                                                                                                                                                                         2.76                                                                                                                                                                                    
                                                                                                                                                                                                                        1 month       5.11      3.13      5.92                                                                                                                                                                                                                                                         5.49                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      4.64      1.22      5.65                                                                                                                                                                                                                                                         1.23                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      5.71      2.38      5.14                                                                                                                                                                                                                                                         0.92                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      4.11      1.30      4.14                                                                                                                                                                                                                                                         0.92                                                                                                                                                                                    No significant effects
                                                                                                                                                                                                                        Single dose   4.89      2.63      5.28                                                                                                                                                                                                                                                         2.76                                                                                                                                                                                    
                                                                                                                                                                                                                        1 month       4.26      0.83      5.92                                                                                                                                                                                                                                                         5.49                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      5.74      2.60      5.65                                                                                                                                                                                                                                                         1.23                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      6.06      3.19      5.14                                                                                                                                                                                                                                                         0.92                                                                                                                                                                                    
                                                                                                                             FSH (IU/L)                     KP 25 mg/day vs placebo          Baseline                   8.80          4.29      7.88      4.34                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        Single dose   7.35      4.23      6.73                                                                                                                                                                                                                                                         2.54                                                                                                                                                                                    
                                                                                                                                                                                                                        1 month       7.23      5.37      6.52                                                                                                                                                                                                                                                         5.51                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      7.96      3.32      5.95                                                                                                                                                                                                                                                         2.34                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      8.81      5.12      5.88                                                                                                                                                                                                                                                         3.34                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      7.53      2.92      7.88                                                                                                                                                                                                                                                         4.34                                                                                                                                                                                    No significant effects
                                                                                                                                                                                                                        Single dose   6.14      2.26      6.73                                                                                                                                                                                                                                                         2.54                                                                                                                                                                                    
                                                                                                                                                                                                                        1 month       6.29      2.25      6.52                                                                                                                                                                                                                                                         5.51                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      6.01      2.79      5.95                                                                                                                                                                                                                                                         2.34                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      7.03      2.35      5.88                                                                                                                                                                                                                                                         3.34                                                                                                                                                                                    
                                                                                                                             LH (IU/L)                      KP 25 mg/day vs placebo          Baseline                   7.25          5.90      7.14      5.62                                                                                                                                                                                                                                                         No significant effects                                                                                                                                                                  
                                                                                                                                                                                                                        Single dose   8.12      2.72      7.59                                                                                                                                                                                                                                                         3.21                                                                                                                                                                                    
                                                                                                                                                                                                                        1 month       7.04      5.34      7.30                                                                                                                                                                                                                                                         4.24                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      8.48      4.64      7.82                                                                                                                                                                                                                                                         2.34                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      8.72      4.67      8.14                                                                                                                                                                                                                                                         3.23                                                                                                                                                                                    
                                                                                                                                                                                             KP 90 mg/day vs placebo    Baseline      6.99      4.37      7.14                                                                                                                                                                                                                                                         5.62                                                                                                                                                                                    No significant effects
                                                                                                                                                                                                                        Single dose   7.65      1.88      7.59                                                                                                                                                                                                                                                         3.21                                                                                                                                                                                    
                                                                                                                                                                                                                        1 month       8.55      3.64      7.30                                                                                                                                                                                                                                                         4.24                                                                                                                                                                                    
                                                                                                                                                                                                                        2 months      7.41      4.67      7.82                                                                                                                                                                                                                                                         2.34                                                                                                                                                                                    
                                                                                                                                                                                                                        Delay^b^      8.82      4.44      8.14                                                                                                                                                                                                                                                         3.23                                                                                                                                                                                    

Abbreviations: KP, *Kaempferia parviflora*; VO~2~, oxygen consumption; ROM, range of motion; high-BAT, high brown adipose tissue; low-BAT, low brown adipose tissue; FSH, follicle-stimulating hormone; LH, luteinizing hormone.

^a^Post: immediately after exercise.

^b^Delay: 1 month after the cessation of KP administration.

![Forest plot illustrating the effect of Krachaidum on hand grip strength.](10.1177_2156587216669628-fig3){#fig3-2156587216669628}

Clinical Effects of Krachaidum on Erectile Response {#section12-2156587216669628}
---------------------------------------------------

Only one randomized controlled trial compared Krachaidum with placebo in human subjects on erectile response.^[@bibr34-2156587216669628]^ Subjects receiving Krachaidum 25 mg/day (n = 15), or 90 mg/day (n = 15), were compared with those receiving placebo (n = 15) for 8 weeks of study period. They found that Krachaidum at a dose of 90 mg/day significantly decreased the response latency time to sexual erotic stimulation and still showed significant changes during the delay period. In addition, after 1 month and 2 months, the Krachaidum group at a dose of 90 mg/day experienced a statistically significant increase in length and width of penis both in resting state and erection state compared with the placebo group. Krachaidum showed no effects on serum hormones (ie, follicle-stimulating hormone, luteinizing hormone; [Table 2](#table2-2156587216669628){ref-type="table"}).

Clinical Effects of Krachaidum on Pain Indicators {#section13-2156587216669628}
-------------------------------------------------

A study by Chalee^[@bibr35-2156587216669628]^ compared Krachaidum cream with analgesic cream on pain reduction indicators. Pain severity, circumference of knee joint, range of motion of knee joint, and modified Western Ontario and McMaster Universities Arthritis Index score were assessed and compared within the group from baseline, or between the groups with analgesic cream. Comparing with baseline, the results in both groups showed significantly reduce pain in all indicators at 4 weeks. On the contrary, comparing with analgesic cream, Krachaidum cream showed nonsignificant different ([Table 2](#table2-2156587216669628){ref-type="table"}).

Clinical Effects of Krachaidum on Energy Expenditure {#section14-2156587216669628}
----------------------------------------------------

A study by Matsushita et al^[@bibr36-2156587216669628]^ evaluated the effect of 2 doses of Krachaidum 100 mg/day or 180 mg/day on energy expenditure change compared with placebo. They found that when comparing with baseline, Krachaidum showed significant increase in energy expenditure at 30 minutes and 60 minutes in both groups. However, compared with placebo, no significant additional benefit of Krachaidum on energy expenditure was found ([Table 2](#table2-2156587216669628){ref-type="table"}).

Discussion {#section15-2156587216669628}
==========

This systematic review provides a critical summary of clinical evidence of Krachaidum for all indications. We found a wide variety of use of Krachaidum including physical or exercise performance, erectile response, pain indicators, and energy expenditure. The methodological quality of the 7 randomized controlled trials included in the systematic review was high according to Jadad score, and was ranked as unclear according to Cochrane risk of bias tool. From the included clinical trials, the benefits of Krachaidum remained inconclusive.

Our pooled effect on physical or exercise performance outcomes showed that Krachaidum 90 to 180 mg/day significantly enhanced hand grip strengths compared with placebo.^[@bibr32-2156587216669628],[@bibr33-2156587216669628]^ This might be explained by the increased blood flow effect of Krachaidum.^[@bibr37-2156587216669628]^ A previous study demonstrated that Krachaidum supplementation could increase blood flow to the organs due to vasorelaxation induction. This partly was mediated through cyclooxygenase and nitric oxide--dependent pathways,^[@bibr38-2156587216669628]^ and Krachaidum also showed anti-inflammatory effects.^[@bibr37-2156587216669628],[@bibr39-2156587216669628],[@bibr40-2156587216669628]^ Therefore, the combination effect of increased blood flow and anti-inflammatory effects may facilitate muscle strength.^[@bibr32-2156587216669628],[@bibr33-2156587216669628]^

For erectile response outcome, although only one study was included,^[@bibr34-2156587216669628]^ it showed that subjects receiving Krachaidum 90 mg/day exhibited a significant enhancement in all parameters (ie, response latency time to visual erotic stimuli, size and length of penis both in flaccid and erectile states) after 1 and 2 months of treatment compared with placebo. The authors explained that the effects involved nitric oxide. The experimental studies reported that Krachaidum extract could induce an increase of endothelial nitric oxide synthase and protein expression in human umbilical vein endothelial cell.^[@bibr41-2156587216669628]^ Thus, abundance of endothelial nitric oxide synthase in endothelium of penile vasculature and sinusoidal endothelium within the corpora carvernosa might increase penile erection.^[@bibr42-2156587216669628][@bibr43-2156587216669628]--[@bibr44-2156587216669628]^

For pain indicators, a study comparing Krachaidum cream with analgesic cream in knee osteoarthritis was found.^[@bibr35-2156587216669628]^ Although the findings demonstrated significant pain reduction in all indicators at 4 weeks compared with baseline, but there was no significant difference when compared with analgesic cream. Since anti-inflammatory effect was studied only using oral administration of Krachaidum,^[@bibr40-2156587216669628],[@bibr45-2156587216669628],[@bibr46-2156587216669628]^ the mechanism of Krachaidum cream on pain reduction was still unclear.

Furthermore, the effect of Krachaidum on energy expenditure has been linked to the activity of brown adipose tissue, a site of nonshivering thermogenesis.^[@bibr47-2156587216669628]^ A previous study found that the components of Krachaidum extract activate hormone-sensitive lipase in adipocyte.^[@bibr48-2156587216669628]^ Furthermore, 5,7-dimenthoxyflavone, the major flavonoid in Krachaidum extract, was demonstrated to have a the potent inhibitory effect on eAMP-degrading enzyme.^[@bibr20-2156587216669628]^ Since eAMP is a signal of hormone-sensitive lipase in adipocyte, it activates brown adipose tissue thermogenesis. Thus, it is possible that the brown adipose tissue--mediated thermogenic effect of Krachaidum extract exist via the inhibition of phosphodiesterase in brown adipose tissue. A study showed that Krachaidum extract could potentially increase whole-body energy expenditure probably through the activation of brown adipose tissue, which might benefit as an antiobesity regimen.^[@bibr36-2156587216669628]^

Considering safety issues, adverse events were not reported among all included studies. An animal study of Krachaidum extract on chronic toxicity was conducted.^[@bibr23-2156587216669628]^ They randomly divided 120 Wistar rats into 5 groups, 24 rats each (12 males and 12 females). Then, 3 treatment groups were orally administered with Krachaidum extract at doses of 5, 50, and 500 mg/kg/day for 6 months, respectively, which were equivalent to 1, 10, and 100 times that of human use, while 2 control groups were orally given distilled water and 1.0% tragacanth, respectively. The results showed that the histopathological study of visceral organs revealed no remarkable lesions related to the toxicity of Krachaidum extract.

The limitations of this study should be noted. First, we found limited number of studies to be included. Thus, pooling effect is impossible. Even when possible (ie, hand grip strengths), only 2 studies were pooled; therefore, conclusive findings could not be determined. Second, this systematic review had diversity of Krachaidum dosage regimens (ie, from 25 mg/day to 1.35 g/day), dosage forms (ie, capsule, cream), or extraction method (60% or 95% ethanol extraction) across studies. Applying the results to clinical practice is limited.

Conclusion {#section16-2156587216669628}
==========

In summary, although various indications of Krachaidum were found with varying qualities of evidence, the positive benefits of Krachaidum were reported, and adverse events were not found. As a very small number of studies were included, it would be difficult to make reliable conclusions. Additional clinical studies with larger sample sizes are needed.
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